Test-retest reproducibility of PET scan with adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers.

Test-retest reproducibility of PET scan with adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers. - Reproducibility study of [C-11] Preladenant

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030040

Enrollment

Registered

2017-11-20

Start date

2017-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

The dosage in the vain of [C-11]Preladenant for PET/CT imaging will be performed twice within 12 months interval.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. The subject who has intention to participate in this study, and signed informed consent. 2. Male subject of >=20 and <60 years old. The subject who judged by clinical investigator by means of physical examination and laboratory tests to be eligible as a participant in this study.

Exclusion criteria

Exclusion criteria: 1. The subject who has dysfunction in the liver / kidney. 2. The subject who has abnormal findings in the central nervous system. 3. The subject having cardiac failure. 4. The subject with a history of a drug or food allergy. 5. Smokers The subject who juddged by the clinical investigator to be inappropriate as a participant in this study.

Design outcomes

Primary

Measure	Time frame
Reproducilibity of PET measures between test-retest scans within 12 months interval.	—

Countries

Japan

Contacts

Public ContactKenji Ishii

Tokoyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

ishii@pet.tmig.or.jp0339643241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026